EOLS (STOCKS)
Evolus, Inc. Common Stock
$4.300000
-0.150000 (-3.37%)
Prev close: $4.450000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David Moatazedi
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $278.73M
- Employees
- 329
- P/E (TTM)
- -4.71
- P/B (TTM)
- -9.68
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $285.82M |
| Benefits Costs and Expenses | $343.65M |
| Cost Of Revenue | $95.37M |
| Costs And Expenses | $229.65M |
| Gross Profit | $190.45M |
| Operating Expenses | $229.65M |
| Selling, General, and Administrative Expenses | $216.38M |
| Other Operating Expenses | $12.01M |
| Operating Income/Loss | -$39.20M |
| Income/Loss From Continuing Operations After Tax | -$58.56M |
| Income/Loss From Continuing Operations Before Tax | -$57.83M |
| Income Tax Expense/Benefit | $732.00K |
| Income Tax Expense/Benefit, Deferred | -$29.00K |
| Net Income/Loss | -$58.56M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$58.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$58.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.91 |
| Diluted Earnings Per Share | -$0.91 |
| Basic Average Shares | 193,416,239 |
| Diluted Average Shares | 193,416,239 |
| Assets | $219.00M |
| Current Assets | $134.89M |
| Inventory | $32.87M |
| Prepaid Expenses | $4.60M |
| Other Current Assets | $97.41M |
| Noncurrent Assets | $84.11M |
| Fixed Assets | $5.13M |
| Intangible Assets | $48.72M |
| Other Non-current Assets | $30.26M |
| Liabilities | $247.76M |
| Current Liabilities | $66.71M |
| Accounts Payable | $22.96M |
| Wages | $9.13M |
| Other Current Liabilities | $34.62M |
| Noncurrent Liabilities | $181.05M |
| Equity | -$28.76M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$28.76M |
| Liabilities And Equity | $219.00M |
| Net Cash Flow From Operating Activities | -$50.28M |
| Net Cash Flow From Operating Activities, Continuing | -$50.28M |
| Net Cash Flow From Investing Activities | -$7.65M |
| Net Cash Flow From Investing Activities, Continuing | -$7.65M |
| Net Cash Flow From Financing Activities | $15.95M |
| Net Cash Flow From Financing Activities, Continuing | $15.95M |
| Exchange Gains/Losses | $473.00K |
| Net Cash Flow | -$41.51M |
| Net Cash Flow, Continuing | -$41.99M |
| Comprehensive Income/Loss | -$58.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$58.01M |
| Other Comprehensive Income/Loss | -$22.28M |
| Other Comprehensive Income/Loss Attributable To Parent | $552.00K |